KRYS
Krystal BiotechANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
KRYS vs peer average
95/100
KRYS vs. peer average (A vs. D)
Grade spread
A 1 · C 2 · D 3 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AXSM is the first available peer comparator.
A similarly sized commercial-stage biotech, but its neuroscience portfolio is not a direct VYJUVEK or gene-therapy comparable.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KRYS
Krystal Biotech
AXSM
Axsome Therapeutics
Grade
A
C
Momentum
63
11
Value
59
41
Sentiment
66
77
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs AXSM
KRYS / AXSM
Grade Position
Above peers
KRYS vs. peer average (A vs. D)
95/100
Momentum
63
KRYSValue
59
KRYSSentiment
66
AXSMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KRYS
AXSM is the first peer returned for this comparison set.